These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7160047)

  • 1. Combination of dacarbazine and mitomycin in advanced colorectal cancer.
    Bleiberg H; Clavel M; Nicaise C; Devriendt J; Michel J; Vanderlinden B; Rozencweig M
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):68-9. PubMed ID: 7160047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer.
    Falkson G; Pretorius HL; Falkson HC; Schoeman HS
    Cancer Chemother Pharmacol; 1983; 11(3):203-4. PubMed ID: 6416696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
    Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
    Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of a 5-fluorouracil, teniposide and mitomycin-C combination chemotherapy in advanced colorectal carcinomas.
    Becouarn Y; Calabet J; Brunet R
    Tumori; 1988 Feb; 74(1):75-7. PubMed ID: 3127973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorouracil (NSC-19893), DTIC (NSC-45388), BCNU (NSC-409962), and vincristine (NSC-67574) in advanced colorectal carcinoma.
    von Eyben FE; Larsen V; Pedersen H
    Cancer Treat Rep; 1976 Jan; 60(1):29-32. PubMed ID: 1000517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
    Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
    Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
    Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
    J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
    Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
    Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of dacarbazine imidazole carboxamide and mitomycin C combination therapy in patients with adenocarcinoma of the colon refractory to 5-fluorouracil therapy.
    Conroy JF; Roda PI; Brodsky I; Kahn SB; Bulova SI; Pequignot E
    Recent Results Cancer Res; 1981; 79():93-100. PubMed ID: 6795702
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275).
    Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
    Cancer; 1982 Apr; 49(8):1555-60. PubMed ID: 7039814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion.
    Kane RC; Cashdollar MR; Bernath AM
    Cancer Treat Rep; 1978 Oct; 62(10):1521-5. PubMed ID: 709554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current protocol approaches in large bowel cancer.
    Carter SK
    Semin Oncol; 1976 Dec; 3(4):433-43. PubMed ID: 793018
    [No Abstract]   [Full Text] [Related]  

  • 13. Pelvic intra-arterial mitomycin C infusion in previously treated patients with metastatic, unresectable, pelvic colorectal cancer and angiographic determination of tumor vascularity.
    Tseng MH; Park HC
    J Clin Oncol; 1985 Aug; 3(8):1093-100. PubMed ID: 3926959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.
    Feliu J; González Barón M; Espinosa E; García Girón C; de la Gándara I; Espinosa J; Colmenarejo A; Jalón JI; Fernández Y; de Castro J
    Cancer; 1997 May; 79(10):1884-9. PubMed ID: 9149013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II evaluation of aclacinomycin A (ACM-A, NSC208734) in patients with metastatic colorectal cancer.
    Bedikian AY; Stroehlein J; Korinek J; Karlin D; Valdivieso M; Bodey G
    Am J Clin Oncol; 1983 Apr; 6(2):187-90. PubMed ID: 6572470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience.
    Lin JK; Wang WS; Hsieh RK; Hsu TC; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Jpn J Clin Oncol; 2000 Nov; 30(11):510-4. PubMed ID: 11155922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma.
    Wils J; Schlangen J; Naus A
    Cancer Chemother Pharmacol; 1984; 13(3):215-7. PubMed ID: 6548420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of combination chemotherapy of colonic cancer with 5-fluorouracil, mitomycin C, and hexamethylmelamine.
    Bruckner HW; Storch JA; Brown JC; Goldberg J; Chamberlin K
    Oncology; 1983; 40(3):161-4. PubMed ID: 6405337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical study of mitomycin C (NSC-26980) in colorectal cancer.
    Ansfield FJ
    Cancer Chemother Rep; 1969 Oct; 53(5):287-9. PubMed ID: 5377615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.